ESR1 and breast cancer: The 27-hydroxycholesterol (27-HC) is an oxysterol and is the first known endogenous selective estrogen receptor modulator (SERM) (1) that has been proven to enhance estrogen receptor (ER)-positive breast cancer (BC) proliferation via estrogen receptor alpha (ERα) (2).